SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-20-088216
Filing Date
2020-07-30
Accepted
2020-07-30 11:12:36
Documents
1
Group Members
BPIFRANCE INVESTISSEMENT S.A.S.BPIFRANCE S.A.CAISSE DES DEPOTSEPIC BPIFRANCEFONDS INNOBIO FPCI

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a20-25886_1sc13da.htm SC 13D/A 287879
  Complete submission text file 0001104659-20-088216.txt   289624
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Subject) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87213 | Film No.: 201059717
SIC: 2834 Pharmaceutical Preparations

Mailing Address 27-31 AVENUE DU GENERAL LECLERC MAISONS ALFORT, CEDEX I0 94710
Business Address 27-31 AVENUE DU GENERAL LECLERC MAISONS ALFORT, CEDEX I0 94710 33153898789
Bpifrance Participations SA (Filed by) CIK: 0001581835 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A